These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 39053286)

  • 1. Letter to the editor, "Clinical benefits of combining oral cytotoxic chemotherapeutic agents with radiotherapy in patients with T2N0 glottic squamous cell carcinoma based on the reports of the head and neck Cancer Registry of Japan.".
    Jeyaraj G
    Oral Oncol; 2024 Oct; 157():106974. PubMed ID: 39053286
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical benefits of combining oral cytotoxic chemotherapeutic agents with radiotherapy in patients with T2N0 glottic squamous cell carcinoma based on the reports of the Head and Neck Cancer Registry of Japan.
    Ichisaka T; Sano D; Kijima N; Kawakita D; Yoshimoto S; Kitayama M; Nibu KI; Oridate N
    Oral Oncol; 2024 Oct; 157():106942. PubMed ID: 39029387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical evaluation of a prospective study of concurrent chemoradiotherapy with S-1 for early glottic carcinoma.
    Kimura K; Itoh Y; Okada T; Nakahara R; Kawamura M; Kubota S; Itoh J; Hiramatsu M; Fujimoto Y; Shibata T; Naganawa S
    Anticancer Res; 2015 Apr; 35(4):2385-90. PubMed ID: 25862904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WRAP53β, survivin and p16INK4a expression as potential predictors of radiotherapy/chemoradiotherapy response in T2N0-T3N0 glottic laryngeal cancer.
    Tiefenböck-Hansson K; Haapaniemi A; Farnebo L; Palmgren B; Tarkkanen J; Farnebo M; Munck-Wikland E; Mäkitie A; Garvin S; Roberg K
    Oncol Rep; 2017 Oct; 38(4):2062-2068. PubMed ID: 28849066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and costs of treatment-related complications among patients with advanced squamous cell carcinoma of the head and neck.
    Lang K; Sussman M; Friedman M; Su J; Kan HJ; Mauro D; Tafesse E; Menzin J
    Arch Otolaryngol Head Neck Surg; 2009 Jun; 135(6):582-8. PubMed ID: 19528407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent chemoradiotherapy with S-1 for T2N0 glottic squamous cell carcinoma.
    Nonoshita T; Shioyama Y; Nakamura K; Nakashima T; Ohga S; Yoshitake T; Ohnishi K; Terashima K; Asai K; Honda H
    J Radiat Res; 2010; 51(4):481-4. PubMed ID: 20601829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy in the management of glottic squamous cell carcinoma.
    Mendenhall WM; Strojan P; Lee AWM; Rinaldo A; Eisbruch A; Ng WT; Smee R; Ferlito A
    Head Neck; 2020 Dec; 42(12):3558-3567. PubMed ID: 32896071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of concomitant chemoradiation in locally advanced head and neck cancers.
    Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
    Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment and Survival Trends in Glottic Carcinoma in Situ and Stage I Cancer From 1988 to 2012.
    Khaja SF; Hoffman HT; Pagedar NA
    Ann Otol Rhinol Laryngol; 2016 Apr; 125(4):311-6. PubMed ID: 26481178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quality of life after simultaneous radiochemotherapy in squamous cell carcinoma of the head and neck].
    Wendt TG
    Strahlenther Onkol; 2000 Apr; 176(4):198-200. PubMed ID: 10812396
    [No Abstract]   [Full Text] [Related]  

  • 11. Superselective intra-arterial chemoradiation therapy for functional laryngeal preservation in advanced squamous cell carcinoma of the glottic larynx.
    Furusaka T; Matsuda A; Tanaka A; Matsuda H; Ikeda M
    Acta Otolaryngol; 2013 Jun; 133(6):633-40. PubMed ID: 23394224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of concurrent carboplatin plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin.
    Hamauchi S; Yokota T; Onozawa Y; Ogawa H; Onoe T; Kamijo T; Iida Y; Nishimura T; Onitsuka T; Yasui H
    Jpn J Clin Oncol; 2015 Dec; 45(12):1116-21. PubMed ID: 26423341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effective analysis of non-surgical combined treatments for laryngeal organ preservation in locally advanced laryngeal carcinoma].
    Yan F; Zhang X; Ma L; Liu M; Chen N; Wang J; Wu W; Huang D
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 May; 51(5):372-7. PubMed ID: 27220298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is induction chemotherapy the new standard in organ preservation treatment for locally advanced head and neck cancer in 2010?
    Porceddu SV
    Asia Pac J Clin Oncol; 2010 Jun; 6(2):75-6. PubMed ID: 20565417
    [No Abstract]   [Full Text] [Related]  

  • 15. Incidence of and survival after glottic squamous cell carcinoma in Denmark from 1971 to 2011-A report from the Danish Head and Neck Cancer Group.
    Lyhne NM; Johansen J; Kristensen CA; Andersen E; Primdahl H; Andersen LJ; Oksbjerg S; Overgaard J
    Eur J Cancer; 2016 May; 59():46-56. PubMed ID: 27014799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk-adapted partial larynx and/or carotid artery sparing modulated radiation therapy of glottic cancer.
    Janssen S; Glanzmann C; Huber G; Studer G
    Radiat Oncol; 2014 Jun; 9():136. PubMed ID: 24923417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of intensity-modulated radiotherapy in Stage IV head-and-neck squamous cell carcinoma.
    Dirix P; Nuyts S
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1373-80. PubMed ID: 20362402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non- inferior moderate hypofractionated irradiation of glottis T1/T2 laryngeal cancer ].
    Becker-Schiebe M; Christiansen H
    Strahlenther Onkol; 2014 Jul; 190(7):694-5. PubMed ID: 24770939
    [No Abstract]   [Full Text] [Related]  

  • 19. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
    Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
    Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Concurrent chemoradiotherapy with S-1 for T2N0 glottic carcinoma].
    Ikeda Y; Tsukuda M; Tanigaki Y; Yabuki K; Mitake D; Ishitoya J
    Gan To Kagaku Ryoho; 2008 May; 35(5):789-92. PubMed ID: 18487914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.